AI-based analysis uncovers two plant extracts with potential as GLP-1 agonist weight loss pills

Two plant compounds with potential as GLP-1 agonist weight loss pills have been identified in an AI (artificial intelligence)-based study, the European Congress on Obesity (ECO 2024) (Venice 12-15 May), will hear.

Amgen reports 45.9% decline in net income to $746m in Q2 2024

For the three months ended 30 June 2024, Amgen’s GAAP EPS decreased by 46% to $1.38 from $2.57 in Q2 2023. Credit: Amgen Inc. Amgen

August 7, 2024

Infectious disease trends for CROs in 2024

CROs working within trials for infectious diseases face a number of challenges post-pandemic. Credit: Gorodenkoff via Shutterstock. The global healthcare sector has witnessed both unprecedented

May 10, 2024

InSilicoTrials, Axoltis to develop drugs for neurological disorders

The partnership aims to develop disease-modifying drugs to treat patients with neurodegenerative and traumatic neurologic impairments. Credit: Elif Bayraktar / Shutterstock.com. InSilicoTrials has entered a

July 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.